Arsenal Capital Partners Adds Raymond H. Hill as an Operating Partner [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
technology-rich, market-leading healthcare and industrial growth companies, today announced that it has expanded its team with the addition of Raymond ("Ray") H. Hill. Mr. Hill will work as an Operating Partner within the firm's healthcare team and will focus on pharmaceutical services investment themes and portfolio companies. Mr. Hill was most recently Chairman and CEO of CorEvitas, LLC ("CorEvitas"). Mr. Hill built CorEvitas into an industry leader in providing real-world evidence to assess the safety and clinical effectiveness of therapies in autoimmune and inflammatory-mediated diseases. Over a nine-year period leading CorEvitas, he oversaw significant growth and two recapitalization events, the most recent of which was the acquisition of CorEvitas by Thermo Fisher Scientific, Inc. for over $900 million Prior to CorEvitas, Mr. Hill was President of InVentiv Clinical (now Syneos Health), a leading clinical research organization. He also served as President of IMS Health ("IMS"
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Thermo Fisher Scientific Inc. (NYSE: TMO) had its price target raised by analysts at HSBC Holdings plc from $660.00 to $670.00. They now have a "buy" rating on the stock.MarketBeat
- Single-use Bioreactors Market to hit USD 9.2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- In Vitro Fertilization Market Projected to Reach US$ 1,940.8 Million Valuation by 2034: Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- Cancer Biomarkers Market Worth $42.0 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 4/24/24 - Beat
TMO
Sec Filings
- 4/30/24 - Form 144
- 4/29/24 - Form 4
- 4/29/24 - Form 144
- TMO's page on the SEC website